About Precera Bioscience
Precera Bioscience is a Healthcare company based in Franklin (United States) founded in 2013 by Murray Blackshear. It operates as a medication Management and tracking solution for healthcare providers and Payers. Precera Bioscience has raised $6.93 million across 1 funding round. Its chief executive is Pamela Weir. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Patient Engagement. Its competitors include Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
Precera Bioscience was founded in 2013 in Franklin, United States, focusing on healthcare technology. Clinical solutions are offered for precise detection of medication efficacy in patients. Patient Medication Profile analytics are provided, delivering data on therapy adherence, drug levels within reference ranges, clinical value, and potential interactions. Care teams are informed to enable adjustments in treatment plans for improved outcomes, addressing limitations in existing medication therapy management programs.
- Headquarters Franklin, United States
- Founders Murray Blackshear
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website precera.com
- Total Equity Funding$6.93M (USD)
in 1 rounds
- Latest Funding Round$6.93M (USD), Series A
Nov 2017
Funding Insights of Precera Bioscience
Precera Bioscience has successfully raised a total of $6.93M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.93 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.93M
- Total Rounds 1
- Last Round Series A — $6.93M
- First Round $6.93M
(Nov 2017)
All 1 funding rounds of Precera Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $6.93M | Series A | – | – | – |
People of Precera Bioscience
2 people are tracked at Precera Bioscience (2 in leadership).
| Name | Role | Group |
|---|---|---|
Murray Blackshear | Co-Founder & Chairman | Leadership |
Pamela Weir | CEO & President | Leadership |
Complete people profiles for Precera Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Precera Bioscience
2 dated milestones of Precera Bioscience across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Precera Bioscience is founded.
- Funding First funding round of $6.9M.
Competitors of Precera Bioscience
Precera Bioscience has 8 listed competitors in our database, 7 of them funded. They include Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| genuitysci.com | 2013 | Boston, United States | $515M | – | AI-based omics data analysis solutions are provided to researchers. | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| depixus.com | 2012 | Paris, France | $34.52M | – | Single-molecule genetic and epigenetic sequencing solutions are provided. | |
| genomics.com | 2014 | Oxford, United Kingdom | $115.54M | – | Genomic risk assessment and prevention platform is provided. | |
| sevenbridges.com | 2009 | Cambridge, United States | $113M | 112 | Cloud-based platform to analyze, store, and act on genomic data. |
Detailed competitors of Precera Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
10 companies that operate in the same segment as Precera Bioscience (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 716.99 M | – | 1,832 | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | 1,746 | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 473.73 M | – | 3,902 | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, Ile de France, France | USD 863.12 M | – | 1,606 | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | 992 | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | 2,470 | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Precera Bioscience
Complete news archive for Precera Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precera Bioscience
Precera Bioscience was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Precera Bioscience is headquartered in Franklin, United States.
Pamela Weir is the current CEO of Precera Bioscience.
Precera Bioscience is a funded company, having raised a total of $6.93M across 1 funding round to date. The company's 1st funding round was a Series A of $6.93M, raised on Nov 2017.
Precera Bioscience was founded in 2013 in Franklin, United States, focusing on healthcare technology. Clinical solutions are offered for precise detection of medication efficacy in patients. Patient Medication Profile analytics are provided, delivering data on therapy adherence, drug levels within reference ranges, clinical value, and potential interactions. Care teams are informed to enable adjustments in treatment plans for improved outcomes, addressing limitations in existing medication therapy management programs.
Precera Bioscience's top competitors include Helix, Benchling and BioAge Labs.